| June 30, 2001 € |
December 31, 2000 € |
|
|
|
||
| Intangible fixed assets............................................ | 232 | 162 |
| Property, plant and equipment............................... | 3,742 3,974 |
852 1,020 |
|
|
||
| Inventories............................................................. | 129 | 6 |
| Customer and associates accounts......................... | 5,224 | 872 |
| Other accounts receivable and associates accounts | 3,082 | 674 |
| Cash equivalents .................................................. | 80,733 | 16 |
| Cash...................................................................... | 2,767 91,935 |
9,639 11,207 |
| Total Assets |
95,909 |
12,227 |
|
|
||
| Capital................................................................... | 2,690 | 2,048 |
| Additional paid-in capital...................................... | 93,676 | 11,014 |
| Reserves and consolidated statements.................. | (2,418) | (2,714) |
| Cumulative translation adjustment........................ | (333) 93,615 |
11 10,359 |
|
|
||
| Borrowings and financial liabilities....................... | 213 | 213 |
| Accounts payable.................................................. | 884 | 187 |
| Other liabilities and associates accounts............... | 1,197 2,294 |
1,468 1,868 |
| 95,909 |
12,227 |
| Half
period ending June 30 |
Year ending December 31 |
||
| 2001 |
2000 |
2000 |
|
| € | € | € | |
| Revenues........................................................ | 6,061 | 1,164 | 3,057 |
| Sales cost....................................................... | (154) |
(71) |
(268) |
| Profit
Margin............................................. |
5,907 |
1,093 |
2,789 |
| Operating expenses : | |||
| Research and development expenses............ | (2,466) | (1,236) | (2,761) |
| Selling and marketing expenses ................... | (3,107) | (799) | (2,592) |
| General and administrative expenses............ | (1,369) |
(111) |
(924) |
| Total operating
expenses......................... |
(6,942) |
(2,146) |
(6,277) |
| Operational
result.............................. |
(1,035) |
(1,053) |
(3,488) |
| Interest expenses.......................................... | (114) | (13) | (9) |
| Interest income ............................................ | 1,366 | 512 | 363 |
| Foreign exchange gain (loss) ...................... | 140 |
0 |
501 |
| |
357 |
(554) |
(2,633) |
| Corporation tax............................................ | - | 12 | |
| Net income
(loss).................................... |
357 |
(554) |
(2,621) |
| Net earning (loss) per share.......................... | 0.007 | (0.02) | (0.07) |
| Number of shares
........................................ |
53,813,511 | 33,895,593 | 37,422,345 |
| Net diluted earning (loss) per share.............. | 0.006 | (0.02) | (0.07) |
| Number of shares fully diluted ..................... | 59,567,511 | 33,895,593 | 37,422,345 |
| Half period ending
June 30, 2001 € |
Year ending December
31, 2000 € |
|
| Cash flows from operating activities : | ||
| Net income (loss).................................................... | 357 | (2,621) |
| Suppression of non monetary elements : | ||
| Amortization and depreciation.......................... | 362 | 298 |
| Cash increase (decrease) on: | ||
| Accounts receivable..................................... | (4,367) | (172) |
| Inventories .................................................. | (124) | 15 |
| Other accounts receivable,
prepayments and accrued income |
(2,075) | (609) |
| Accounts payable ....................................... | 748 | 14 |
| Accrued expenses and other debts.............. | (270) |
1,182 |
| Cash flows from operating activities....... | (5,370) |
(1,893) |
|
|
||
| Property, plant and equipment acquisition ............. | (3,344) | (819) |
| Intangible fixed assets acquisition........................... | (209) |
(282) |
| Cash flows from investment activities....... | (3,553) |
(1,101) |
|
|
||
| New loans................................................................ | - | - |
| Additional paid-in capital........................................ | 83,240 |
11,212 |
| Cash flows from financing
activities......... |
83,240 |
11,212 |
| Effect of exchange rate on C & C Equival............... | (472) |
51 |
| Variation of C & C
equival...................................... |
73,845 |
8,269 |
| C & C equival. Beginning of period........................ | 9,655 |
1,386 |
| C & C equival. End of period.................................. | 83,500 |
9,655 |
Grenoble, France
and Durham, North Carolina, September 28, 2006 –
MEMSCAP (Euronext:
MEMS), the leading provider of innovative solutions based on MEMS
(micro-electro-mechanical systems)
technology, today announces that it will attend the 6th edition of the
2006 « Midcap Events » 2006 that will
be held at Palais Brongniart in Paris, on September 28 and 29.
For this financial event dedicated to meetings between European
institutional investors and French, Belgian,
Dutch, and Portuguese small and midcap companies listed on the Euronext
market, 350 institutional investors
are awaited as well as 10 major brokers, Arkeon Finance which will host
MEMSCAP, Avenir Finance,
Euroland Finance, Gilbert Dupont, ING, Millennium BCPI, Natexis
Bleichroeder, Oddo Midcaps,
Portzamparc Société de Bourse , and SNS
Securities.
Listed since 2001 and
belonging to the Next Economy segment, MEMSCAP (ISIN code: FR0010298620-
MEMS) is the first MEMS company in the world to be listed on a stock
market. With a unique expertise, a
vast technology portfolio, and leading edge products for a wide variety
of applications and markets, the
MEMSCAP Group, that has just realised a reverse stock split and the
listing of these new shares under the
ticker symbol MEMS, has recently announced the strongest semester of
growth in its history with a 77%
compared revenue growth increase, a total annulment of the Group
financial liabilities after the sale of the
Bernin industrial site to SOITEC (Euronext SOI) , a net cash situation
over 10 million euros, as well as a per
head productivity doubled over a year.
Israel R&D fund GalayOr MEMSCAP bird
